Title |
Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
|
---|---|
Published in |
Alzheimer's Research & Therapy, November 2013
|
DOI | 10.1186/alzrt219 |
Pubmed ID | |
Authors |
Noemí Esteras, Carolina Alquézar, Ana de la Encarnación, Alberto Villarejo, Félix Bermejo-Pareja, Ángeles Martín-Requero |
Abstract |
The clinical features of Alzheimer's disease (AD) overlap with a number of other dementias and conclusive diagnosis is only achieved at autopsy. Accurate in-life diagnosis requires finding biomarkers suitable for early diagnosis, as well as for discrimination from other types of dementia. Mounting evidence suggests that AD-dependent processes may also affect peripheral cells. We previously reported that calmodulin (CaM) signaling is impaired in AD lymphoblasts. Here, we address the issue as to whether the assessment of CaM levels in peripheral cells could serve as a diagnostic biomarker. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Australia | 1 | 1% |
Unknown | 65 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 19% |
Student > Postgraduate | 7 | 10% |
Professor | 7 | 10% |
Researcher | 6 | 9% |
Student > Master | 6 | 9% |
Other | 12 | 18% |
Unknown | 16 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 13 | 19% |
Agricultural and Biological Sciences | 11 | 16% |
Medicine and Dentistry | 8 | 12% |
Chemistry | 4 | 6% |
Neuroscience | 4 | 6% |
Other | 8 | 12% |
Unknown | 19 | 28% |